Benjamin R. Brenner
#134,450
Most Influential Person Now
Benjamin R. Brenner's AcademicInfluence.com Rankings
Benjamin R. Brennerphilosophy Degrees
Philosophy
#6707
World Rank
#9794
Historical Rank
Logic
#3831
World Rank
#5049
Historical Rank

Download Badge
Philosophy
Benjamin R. Brenner's Degrees
- Doctorate Medicine University of California, San Francisco
- Masters Public Health University of California, Berkeley
Why Is Benjamin R. Brenner Influential?
(Suggest an Edit or Addition)Benjamin R. Brenner's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Oral rivaroxaban for symptomatic venous thromboembolism. (2010) (2225)
- Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial (2008) (1115)
- Fibrinolysis for patients with intermediate-risk pulmonary embolism. (2014) (1108)
- Haemostatic changes in pregnancy. (2004) (708)
- International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer (2013) (636)
- Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer. (2020) (484)
- 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. (2019) (359)
- Prothrombin complex concentrate (Beriplex® P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial (2008) (313)
- International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer. (2016) (311)
- Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis. (1996) (285)
- Gestational Outcome in Thrombophilic Women with Recurrent Pregnancy Loss Treated by Enoxaparin (2000) (284)
- Fondaparinux for the treatment of superficial-vein thrombosis in the legs. (2010) (277)
- International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer (2012) (271)
- Thrombophilic Polymorphisms Are Common in Women with Fetal Loss without Apparent Cause (1999) (261)
- A single genetic origin for a common Caucasian risk factor for venous thrombosis. (1997) (250)
- Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. (2002) (222)
- Monocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells (2008) (217)
- Overview of hemostasis (2002) (205)
- Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE‐ENOX study (2005) (204)
- Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study (2007) (202)
- Haematological cancers in pregnancy (2012) (144)
- Rationale, Design and Methodology of the Computerized Registry of Patients with Venous Thromboembolism (RIETE) (2018) (134)
- Cardiac involvement in patients with primary antiphospholipid syndrome. (1991) (127)
- Increased risk of cancer in patients with gaucher disease (1993) (123)
- A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. (2006) (121)
- A Missense Mutation in γ-Glutamyl Carboxylase Gene Causes Combined Deficiency of All Vitamin K-Dependent Blood Coagulation Factors (1998) (120)
- Efficacy and safety of a prothrombin complex concentrate (Octaplex) for rapid reversal of oral anticoagulation. (2004) (118)
- Microparticles, thrombosis and cancer. (2009) (114)
- Involvement of microparticles in diabetic vascular complications (2011) (113)
- Maternal extracellular vesicles and platelets promote preeclampsia via inflammasome activation in trophoblasts. (2016) (113)
- Thrombophilia-associated pregnancy wastage. (1999) (109)
- Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation (2005) (108)
- Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study (2018) (108)
- Prophylactic therapy with enoxaparin during l-asparaginase treatment in children with acute lymphoblastic leukemia (2000) (107)
- Activated Protein C Resistance and Factor V Leiden Mutation can be Associated with First‐ as well as Second‐Trimester Recurrent Pregnancy Loss 1 (2000) (106)
- The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin. (1997) (103)
- Nitric oxide: a key factor behind the dysfunctionality of endothelial progenitor cells in diabetes mellitus type-2. (2011) (102)
- Nitric oxide and superoxide dismutase modulate endothelial progenitor cell function in type 2 diabetes mellitus (2009) (98)
- Heparanase, heparin and the coagulation system in cancer progression. (2007) (93)
- Dental surgery in patients with severe factor XI deficiency without plasma replacement. (1992) (91)
- Pulmonary hemorrhage: A novel mode of therapy. (2009) (90)
- Paediatric cerebral sinus vein thrombosis (2004) (90)
- Variant Bernard-Soulier syndrome associated with a homozygous mutation in the leucine-rich domain of glycoprotein IX. (1994) (89)
- Tissue factor and cancer. (2008) (88)
- Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental hemostasis (2004) (88)
- Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry. (2009) (87)
- Inherited Thrombophilia and Pregnancy Loss (1999) (86)
- Bleeding and thrombosis in acute leukemia: what does the future of therapy look like? (2007) (78)
- Venous thromboembolism during pregnancy, postpartum or during contraceptive use (2009) (76)
- Cryogenic Transmission Electron Microscopy Nanostructural Study of Shed Microparticles (2013) (76)
- Familial thrombophilia--the scientific rationale for thrombophylaxis in recurrent pregnancy loss? (1997) (76)
- Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients. (2005) (75)
- Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells (2008) (74)
- Autosomal recessive nephrogenic diabetes insipidus caused by an aquaporin-2 mutation. (1997) (73)
- Hyperglycemia and oxidized-LDL exert a deleterious effect on endothelial progenitor cell migration in type 2 diabetes mellitus. (2010) (71)
- Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study. (2005) (70)
- Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial. (2018) (69)
- Procoagulant and anticoagulant mechanisms in human placenta. (2003) (69)
- A missense mutation in gamma-glutamyl carboxylase gene causes combined deficiency of all vitamin K-dependent blood coagulation factors. (1998) (69)
- Cone and plate(let) analyzer: monitoring glycoprotein IIb/IIIa antagonists and von Willebrand disease replacement therapy by testing platelet deposition under flow conditions. (1998) (69)
- Clinical management of thrombophilia-related placental vascular complications. (2004) (68)
- Thrombophilia and pregnancy loss. (2002) (67)
- Cancer and thrombosis revisited. (2001) (66)
- Angiosarcoma of the colon developing in a capsule of a foreign body. Report of a case with associated hemorrhagic diathesis. (1992) (66)
- Heparanase enhances the generation of activated factor X in the presence of tissue factor and activated factor VII (2010) (64)
- Vitamin K-dependent coagulation factors deficiency. (2009) (63)
- The effect of thrombophylaxis on pregnancy outcome in patients with recurrent pregnancy loss associated with factor V Leiden mutation (2000) (63)
- Hereditary deficiency of all vitamin K‐dependent procoagulants and anticoagulants (1990) (63)
- Heparanase multiple effects in cancer. (2014) (61)
- HELLP syndrome associated with factor V R506Q mutation (1996) (59)
- Haemostatic mechanisms in human placenta. (2003) (56)
- Silent pulmonary embolism in patients with proximal deep vein thrombosis in the lower limbs (2012) (55)
- Meeting report. Acute promyelocytic leukemia-associated coagulopathy, 21 January 2004, London, United Kingdom. (2005) (54)
- Microvesicles of Women With Gestational Hypertension and Preeclampsia Affect Human Trophoblast Fate and Endothelial Function (2013) (54)
- IGIV-C, a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action, and impact on quality of life (2004) (54)
- Evaluation of solvent/detergent treated plasma in the management of patients with hereditary and acquired coagulation disorders (1993) (54)
- Development of a Risk Prediction Score for Occult Cancer in Patients With VTE (2017) (53)
- Orthostatic Hypercoagulability: A Novel Physiological Mechanism to Activate the Coagulation System (2008) (53)
- Thrombophilia and fetal loss. (2003) (52)
- Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications (2004) (52)
- In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes. (1990) (52)
- Thrombohemorrhagic complications of myeloproliferative disorders. (2010) (51)
- Coexistence of familial antiphospholipid syndrome and factor V Leiden: impact on thrombotic diathesis (1996) (51)
- The Effect of Combined Factor XI Deficiency with von Willebrand Factor Abnormalities on Haemorrhagic Diathesis (1990) (51)
- Inherited thrombophilia and poor pregnancy outcome. (2003) (50)
- Bleeding predictors in factor‐XI‐deficient patients (1997) (50)
- Application of a bedside whole blood D‐dimer assay in the diagnosis of deep vein thrombosis (1995) (49)
- Diagnostic studies for thrombophilia in women on hormonal therapy and during pregnancy, and in children. (2002) (48)
- High incidence of myeloproliferative disorders in Ashkenazi Jews in northern Israel. (1992) (48)
- Cerebral thrombosis in a newborn with a congenital deficiency of antithrombin III (1988) (48)
- Hemostatic balance on the surface of leukemic cells: the role of tissue factor and urokinase plasminogen activator receptor. (2005) (48)
- Extracellular vesicles of multiple myeloma cells utilize the proteasome inhibitor mechanism to moderate endothelial angiogenesis (2018) (46)
- Antithrombotic treatment for pregnancy complications: which path for the journey to precision medicine? (2014) (45)
- Arterial thrombosis and cancer. (2018) (45)
- Microparticles and pregnancy complications. (2011) (44)
- Inherited thrombophilia and fetal loss. (2000) (44)
- Adverse obstetric and neonatal outcomes in women with mental disorders. (2015) (43)
- Neonatal IVH--mechanisms and management. (2011) (41)
- Prevalence of Upper Extremity Deep Venous Thrombosis Diagnosed by Color Doppler Duplex Sonography in Cancer Patients With Central Venous Catheters (2006) (41)
- Drug-related thrombosis in hematologic malignancies. (2004) (41)
- Normal response of factor VIII and von Willebrand factor to 1-deamino-8D-arginine vasopressin in nephrogenic diabetes insipidus. (1988) (40)
- Ala244Val Is a Common, Probably Ancient Mutation Causing Factor VII Deficiency in Moroccan and Iranian Jews (1996) (40)
- Thrombophilia and Cancer (2007) (40)
- Arterial Ischemic Events Are a Major Complication in Cancer Patients with Venous Thromboembolism. (2018) (40)
- Reproductive organ involvement in non-Hodgkin lymphoma during pregnancy: a systematic review. (2013) (39)
- Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism (2017) (38)
- SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia (2021) (38)
- Quantitation of venous clot lysis with the D-dimer immunoassay during fibrinolytic therapy requires correction for soluble fibrin degradation. (1990) (38)
- Retinal arterial occlusion in a child with factor V Leiden and thermolabile methylene tetrahydrofolate reductase mutations. (1997) (37)
- Prophylactic therapy with enoxaparin in children with acute lymphoblastic leukemia and inherited thrombophilia during L-asparaginase treatment. (2009) (37)
- Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis. (1996) (36)
- Modulation of systemic hemostatic parameters by enoxaparin during gestation in women with thrombophilia and pregnancy loss (2005) (36)
- A direct-imaging cryo-EM study of shedding extracellular vesicles from leukemic monocytes. (2017) (36)
- Expression and Characterization of the Naturally Occurring Mutation L394R in Human γ-Glutamyl Carboxylase* (2000) (36)
- Control of Bleeding Caused by Thrombocytopenia Associated With Hematologic Malignancy: An Audit of the Clinical Use of Recombinant Activated Factor VII (2005) (35)
- Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis (1996) (35)
- 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19 (2022) (34)
- Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency (2007) (34)
- Heparanase procoagulant activity in cancer progression. (2016) (33)
- Association of homocysteine, vitamin B12, folic acid, and MTHFR C677T in patients with a thrombotic event or recurrent fetal loss (2006) (33)
- Magnetic resonance imaging of blood and clots in vitro. (1990) (32)
- Von Willebrand Factor Multimer Patterns in Pregnancy-Induced Hypertension (1989) (32)
- Visual disturbances and pathologic ocular findings in primary antiphospholipid syndrome. (1999) (31)
- Are the antiplatelet and profibrinolytic properties of selective serotonin-reuptake inhibitors relevant to their brain effects? (2014) (30)
- Clinically relevant bleeding in cancer patients treated for venous thromboembolism from the CATCH study (2018) (30)
- Angioedema during therapy with recombinant tissue plasminogen activator. (1991) (30)
- VTE Registry: What Can Be Learned from RIETE? (2014) (30)
- Assessment and management of high-risk pregnancies in women with thrombophilia. (2009) (29)
- JAK-2 V617F mutation increases heparanase procoagulant activity (2015) (29)
- Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study. (2016) (29)
- Inherited thrombophilia and pregnancy loss. (2003) (28)
- Renal extramedullary hematopoiesis simulating hypernephroma. (1991) (27)
- Comparison of dosage schedules of rt-PA in the treatment of proximal deep vein thrombosis. (1992) (27)
- Tumor‐derived microparticles induce bone marrow‐derived cell mobilization and tumor homing: A process regulated by osteopontin (2014) (27)
- Reactivity patterns of antiphospholipid antibodies and endothelial cells: effect of antiendothelial antibodies on cell migration. (1998) (27)
- Hereditary protein C deficiency during pregnancy. (1987) (27)
- Characterization of negatively charged phospholipids and cell origin of microparticles in women with gestational vascular complications. (2012) (26)
- Diagnosis of femoropopliteal venous thrombosis with MR imaging: a comparison of four MR pulse sequences. (1990) (26)
- Hereditary Deficiency of Vitamin K-dependent Coagulation Factors (2000) (26)
- Thrombotic complications associated with stem cell transplantation. (2012) (26)
- Early Use of Echocardiography in Patients With Acute Pulmonary Embolism: Findings From the RIETE Registry (2018) (26)
- Dehydration as a Possible Cause of Monthly Variation in the Incidence of Venous Thromboembolism (2016) (26)
- An assay to evaluate heparanase procoagulant activity. (2011) (25)
- Incidence, prognostic significance and therapeutic modalities of central nervous system involvement in multiple myeloma. (1982) (25)
- Relation of plasma D-dimer concentrations to coronary artery reperfusion before and after thrombolytic treatment in patients with acute myocardial infarction. (1989) (25)
- Spontaneous intracranial hemorrhage in immune thrombocytopenic purpura. (1988) (25)
- Emerging options in the treatment of deep vein thrombosis and pulmonary embolism. (2011) (25)
- Heparanase coagulation and cancer progression. (2009) (25)
- Protein C Global Assay in the Evaluation of Women with Idiopathic Pregnancy Loss (2002) (24)
- Lower limb ischaemia in primary antiphospholipid syndrome. (1993) (24)
- An Update on the Management of Hematologic Malignancies in Pregnancy (2014) (24)
- Heparanase procoagulant activity is elevated and predicts survival in non-small cell lung cancer patients. (2014) (23)
- Hypercoagulation in chronic post-traumatic stress disorder. (2011) (23)
- Thrombophilia and adverse pregnancy outcome. (2006) (23)
- Low-Molecular-Weight Heparin in Women with Repeated Implantation Failure (2011) (23)
- Intraventricular hemorrhage in preterm infants: coagulation perspectives. (2011) (23)
- Multiple retinal arteriolar occlusions associated with coexisting primary antiphospholipid syndrome and factor V Leiden mutation. (2000) (23)
- Disease dynamics in patients with acute myeloid leukemia: new biomarkers. (2015) (23)
- Asymptomatic deep vein thrombosis in advanced cancer patients: The value of venous sonography (2010) (22)
- Red wine consumption improves in vitro migration of endothelial progenitor cells in young, healthy individuals. (2010) (22)
- Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 cases. (1988) (22)
- Hemostasis in normal pregnancy. (2005) (22)
- Heparanase, tissue factor, and cancer. (2008) (22)
- Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism (2017) (22)
- Involvement of Heparanase in early pregnancy losses. (2010) (22)
- Factor XIII Deficiency due to a Leu660Pro Mutation in the Factor XIII Subunit-a Gene in Three Unrelated Palestinian Arab Families (1997) (21)
- Hemorrhagic and thrombotic complications in bone marrow transplant recipients. (2007) (21)
- Peptides inhibiting heparanase procoagulant activity significantly reduce tumour growth and vascularisation in a mouse model (2016) (21)
- Thrombophilia and pregnancy complications (2004) (21)
- COMMENTARY: Thrombophilia and pregnancy loss in first intended pregnancy (2005) (21)
- The promise of novel direct oral anticoagulants. (2012) (21)
- Coagulation, inflammation, and pregnancy complications (2004) (21)
- Intraventricular hemorrhage in preterm infants and coagulation--ambivalent perspectives? (2013) (21)
- Successful use of recombinant activated factor VII in controlling upper gastrointestinal bleeding in a patient with relapsed acute myeloid leukemia (2003) (20)
- Expression and characterization of the naturally occurring mutation L394R in human gamma-glutamyl carboxylase. (2000) (20)
- Extended Thromboprophylaxis with Rivaroxaban Compared with Short-Term Thromboprophylaxis with Enoxaparin after Total Hip Arthroplasty: The RECORD2 Trial. (2007) (20)
- Hyperhomocysteinemia is common in patients with antiphospholipid syndrome and may contribute to expression of major thrombotic events (2002) (20)
- Novel peptides that inhibit heparanase activation of the coagulation system (2014) (20)
- Interventions to prevent venous thrombosis after air travel, are they necessary? Yes (2006) (20)
- Microvesicles of pregnant women receiving low molecular weight heparin improve trophoblast function. (2016) (20)
- Heparanase procoagulant activity is elevated in women using oral contraceptives. (2013) (20)
- Multiple myeloma with pericardial involvement and cardiac tamponade: a report of three patients. (1996) (19)
- Involvement of the heparanase procoagulant domain in bleeding and wound healing (2017) (19)
- Non-Hodgkin lymphomas in pregnancy: tackling therapeutic quandaries. (2014) (19)
- CILIORETINAL ARTERY OCCLUSION: An Ocular Complication of Primary Antiphospholipid Syndrome (1997) (19)
- Successful Use of Recombinant Activated Factor VII (Novoseven®) in Controlling Severe Intra-Abdominal Bleeding after Liver Needle Biopsy (2002) (19)
- Extracellular Vesicle Characteristics in β-thalassemia as Potential Biomarkers for Spleen Functional Status and Ineffective Erythropoiesis (2018) (18)
- Secondary refractory anemia with excess of blasts in transformation terminating as acute lymphoblastic leukemia. (1986) (18)
- Involvement of heparanase in vaginal and cesarean section deliveries. (2010) (18)
- Budd-Chiari syndrome associated with factor V leiden mutation: a report of 6 patients. (1999) (18)
- Pulmonary embolism: Epidemiology and registries. (2015) (18)
- Acquired thrombophilic syndromes. (2001) (18)
- Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in at-risk patient groups: pregnancy, elderly and obese patients (2019) (18)
- The coagulation profile of preterm delivery. (2014) (18)
- Extracellular Vesicles of Alzheimer’s Disease Patients as a Biomarker for Disease Progression (2020) (18)
- A fatal case of enoxaparin induced skin necrosis and thrombophilia (2006) (18)
- Haematological malignancies in pregnancy: An overview with an emphasis on thrombotic risks (2016) (18)
- SARS-CoV-2 vaccine and thrombosis: Expert opinions. (2021) (18)
- Activation of coagulation in amniotic fluid during normal human pregnancy. (2011) (18)
- Comparison of international societal guidelines for the diagnosis of suspected pulmonary embolism during pregnancy. (2020) (17)
- Coagulation and Placenta-Mediated Complications (2014) (17)
- Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19 (2020) (17)
- Management of pregnant women with myeloproliferative neoplasms. (2013) (17)
- Apixaban and Dalteparin for the Treatment of Venous Thromboembolism in Patients with Different Sites of Cancer (2021) (17)
- Heparanase level and procoagulant activity are reduced in severe sepsis (2018) (17)
- Thrombin is a selective inducer of heparanase release from platelets and granulocytes via protease-activated receptor-1 (2017) (17)
- Increased immunoreactivity of plasma after fibrinolytic activation in an anti-DD ELISA system. Role of soluble crosslinked fibrin polymers. (1989) (17)
- Characterization of Three Mutations Causing von Willebrand Disease Type IIA in Five Unrelated Families (1992) (16)
- Corpus Luteum Hemorrhage in Women with Bleeding Disorders (2009) (16)
- Molecular characterization of four novel mutations causing factor VII deficiency. (2000) (16)
- Increased heparanase level and procoagulant activity in orthopedic surgery patients receiving prophylactic dose of enoxaparin. (2012) (16)
- The role of fibrin matrices and tissue factor in early-term trophoblast proliferation and spreading. (2013) (15)
- Thrombophilia and fetal loss. (1997) (15)
- Evaluation of ProC Global assay in women with a history of venous thromboembolism on hormonal therapy (2006) (14)
- Prolonged travel and venous thromboembolism findings from the RIETE registry. (2010) (14)
- Mental Disorders and Thrombotic Risk (2013) (14)
- Venous Sonography for the Diagnosis of Asymptomatic Deep Vein Thrombosis in Patients With Cancer Undergoing Chemotherapy (2004) (14)
- Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac®) in chronic immune thrombocytopenic purpura (2007) (14)
- Thrombophilia related issues in women and children. (2005) (14)
- Coinfection with hepatitis viruses and human immunodeficiency virus in multiply transfused patients. (1994) (13)
- Chemotherapy administration to breast cancer patients affects extracellular vesicles thrombogenicity and function. (2017) (13)
- Clinical experience with Octagam, a solvent detergent (SD) virus inactivated intravenous gammaglobulin. (1996) (13)
- Glanzmann thrombasthenia in two Iraqi-Jewish siblings is caused by a novel splice junction mutation in the glycoprotein IIb. (1998) (13)
- The endothelial tumor suppressor p53 is essential for venous thrombus formation in aged mice. (2018) (13)
- The role of soluble cross-linked fibrin in D dimer immunoreactivity of plasmic digests. (1989) (13)
- Coagulation and Mental Disorders (2014) (13)
- Acute leukemia following chemotherapy and radiation therapy--a report of 15 cases. (1984) (13)
- Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in high-risk patient groups: cancer and critically ill (2019) (13)
- Recurrence of venous thromboembolism in patients with recent gestational deep vein thrombosis or pulmonary embolism: Findings from the RIETE Registry. (2016) (13)
- Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy. (2014) (12)
- Grb2 regulates the proliferation of hematopoietic stem and progenitors cells. (2017) (12)
- Heparanase procoagulant activity. (2012) (12)
- Heparanase—A Link between Coagulation, Angiogenesis, and Cancer (2012) (12)
- Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation. (2017) (11)
- Heparanase procoagulant effects and inhibition by heparins. (2010) (11)
- Cilioretinal artery occlusion: an ocular complication of primary antiphospholipid syndrome. (1997) (11)
- p45 NF-E2 regulates syncytiotrophoblast differentiation by post-translational GCM1 modifications in human intrauterine growth restriction (2017) (11)
- Extracellular Vesicles Reflect the Efficacy of Wheatgrass Juice Supplement in Colon Cancer Patients During Adjuvant Chemotherapy (2020) (11)
- Effects of Acute Stress on Thrombosis (2018) (11)
- Antiphospholipid Antibodies: Neuropsychiatric Presentations (2013) (11)
- High prevalence of activated protein C resistance due to factor V leiden mutation in cases of intrauterine fetal death. (1999) (11)
- Placenta-derived microparticles. (2013) (11)
- Presence of Integrin alpha(IIb)beta 3 in early gestation human trophoblasts: possible involvement of fibrin as a matrix ligand. (2010) (11)
- COVID-19-Associated Hyper-Fibrinolysis: Mechanism and Implementations (2020) (11)
- Intraventricular haemorrhage in preterm infants – Can we improve outcome by addressing coagulation? (2015) (11)
- Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications – Yes (2003) (11)
- The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper (2021) (11)
- Immune-Mediated Coagulopathy in COVID-19 Infection (2020) (11)
- Hydration does not prevent orthostatic hypercoagulability (2009) (11)
- Prospective evaluation of patients hospitalized with venous thromboembolism: comparison between cancer and non-cancer patients. (2006) (10)
- Platelet activation in patients with antiphospholipid syndrome. (1998) (10)
- Management of acute myeloid leukemia during pregnancy. (2014) (10)
- Thrombophilia and adverse pregnancy outcome. (2007) (10)
- Fertility, Infertility and Thrombophilia (2011) (10)
- Women, thrombosis, and cancer: A gender-specific analysis. (2017) (10)
- Evaluation of the Protein C Global Assay During Normal Pregnancy and After Assisted Reproduction (2010) (9)
- Prophylaxis of travel-related thrombosis in women. (2009) (9)
- Prophylaxis for travel‐related thrombosis? Yes (2004) (9)
- Inhalation of a Short-Acting β2-Adrenoreceptor Agonist Induces a Hypercoagulable State in Healthy Subjects (2016) (9)
- Do we need a cancer screening in patients with idiopathic deep vein thrombosis? (2009) (9)
- Heparanase procoagulant activity, factor Xa, and plasminogen activator inhibitor 1 are increased in shift work female nurses (2015) (9)
- Thrombosis in hematological malignancies: mechanisms and implications. (2020) (9)
- Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry. (2019) (9)
- Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients. (2004) (9)
- Letter to the editor: Prophylaxis of thromboembolism during pregnancy in hereditary AT‐III deficiency (1992) (9)
- Hypercoagulability, Parkinsonism, and Gaucher Disease (2013) (9)
- Implementing Thrombosis Guidelines in Cancer Patients: A Review (2014) (9)
- Partial response of meningeal myeloma to craniospinal radiotherapy (1986) (9)
- Thrombosis in vasculitic disorders-clinical manifestations, pathogenesis and management. (2015) (8)
- Chemotherapy administration to breast cancer patients affects extracellular vesicles thrombogenicity and function (2017) (8)
- Neurocognitive dysfunction in the antiphospholipid antibody syndrome (APS) (1996) (8)
- Renal function and clinical outcome of patients with cancer-associated venous thromboembolism randomized to receive apixaban or dalteparin. Results from the Caravaggio trial (2020) (8)
- Heparanase procoagulant activity as a predictor of wound necrosis following diabetic foot amputation. (2016) (8)
- Did Jesus Christ die of pulmonary embolism? (2005) (8)
- Management and outcomes of cancer patients with venous thromboembolism presenting with thrombocytopenia. (2020) (8)
- Small intestinal myeloid metaplasia. (1988) (8)
- [Spontaneous umbilical cord hematoma]. (2005) (7)
- The Chemokine Stromal Cell–Derived Factor-1&agr; Promotes Endothelial Progenitor Cell–Mediated Neovascularization of Human Transplanted Fat Tissue in Diabetic Immunocompromised Mice (2013) (7)
- [Primary hypercoagulable states]. (1987) (7)
- Effects of Low- and High-Dose Chemotherapy Agents on Thrombogenic Properties of Extracellular Vesicles Derived from Breast Cancer Cell Lines (2018) (7)
- Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives (2021) (7)
- Recommendations for the diagnosis and management of vaccine-induced immune thrombotic thrombocytopenia. (2021) (7)
- Hypercoagulability and recurrent miscarriages. (2010) (7)
- Cancer and Thrombosis—New Insights (2018) (7)
- Oral and Poster Presentations (2003) (7)
- Combined Thrombophilia and Obstetric Complications (2009) (7)
- D‐dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry (2020) (7)
- Pancoast's syndrome in multiple myeloma. (1984) (6)
- Relevance of Heparan Sulfate and Heparanase to Severity of COVID-19 in the Elderly (2021) (6)
- The impact of disseminated intravascular coagulation on the outcome of cancer patients with venous thromboembolism. (2015) (6)
- Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years (2019) (6)
- Clinical significance of prothrombin G20210A mutation in homozygous patients (2017) (6)
- Influence of splenectomy on hemostasis in agnogenic myeloid metaplasia. (1987) (6)
- Adult hemolytic uremic syndrome associated with nonimmune deposit crescentic glomerulonephritis and alveolar hemorrhage. (1988) (6)
- Thrombophilia and pregnancy. (2003) (6)
- Novel strategies of coagulation inhibition for reducing tumor growth and angiogenesis. (2018) (6)
- P.76 Low molecular weight heparin in women with repeated implantation failure (2011) (6)
- Thrombophilia and pregnancy (2003) (6)
- COVID-19, hemostasis disorders and risk of thrombotic complications (2020) (6)
- Enoxaparin Use in Pregnancy: State of the Art (2007) (6)
- Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders. (1992) (6)
- The association between poor ovarian response and thrombophilia in assisted reproduction. (2013) (6)
- Microvesicles in Thrombosis and Inflammation. (2016) (6)
- "To drink or not to drink" – is this really the question? (2008) (5)
- Arterial thrombotic syndromes in cancer patients. (2001) (5)
- Maternal anticoagulant prophylaxis for prevention of pregnancy loss in women with thrombophilia (2003) (5)
- Severe pancytopenia due to marked marrow fibrosis associated with angioimmunoblastic lymphadenopathy. (1985) (5)
- Monitoring of Therapy for Deep Vein Thrombosis Using Magnetic Resonance Imaging (1989) (5)
- Extracellular Vesicle MicroRNA That Are Involved in β-Thalassemia Complications (2021) (5)
- Women's issues in thrombosis and hemostasis (2002) (5)
- Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study (2017) (5)
- Recurrent venous thromboembolism and major bleeding in patients with localised, locally advanced or metastatic cancer: an analysis of the Caravaggio study. (2022) (5)
- Cancer in pregnancy: the role of thromboprophylaxis. (2012) (5)
- Efficacy of enoxaparin for improving pregnancy outcomes and uteroplacental blood flow in women with thrombophilia and recurrent pregnancy loss (2004) (5)
- Microparticles and placental hemostasis. (2009) (4)
- [Thrombolytic therapy in deep vein thrombosis]. (1991) (4)
- Malignancies in Pregnancy 3 Haematological cancers in pregnancy (2012) (4)
- Activated Recombinant Factor VII (rFVIIa/NovoSeven®) in the Treatment of Bleeding Complications Following Hematopoietic Stem Cell Transplantation (HSCT). (2004) (4)
- Anticoagulants and chronic kidney disease. (2011) (4)
- Recurrent spontaneous bacterial peritonitis in a patient with polycythemia vera (1988) (4)
- Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism (2021) (4)
- Von Willebrand Factor Antigen and Factor XI Activity Levels As Predictors of Bleeding Tendency in Israeli Patients with Von Willebrand's Disease (1995) (4)
- The role of the fibrinolytic system in female reproductive disorders and depression (2020) (4)
- A novel mutation of antithrombin deficiency in six family siblings and the clinical combat (2015) (4)
- Coagulation and Brain (2013) (4)
- Thrombophilia and Pregnancy Complications (2006) (4)
- Carbamazepine (Tegretol)‐Induced Thrombocytopenia (1993) (4)
- Thrombophilia in Infancy: Factor V Leiden and MTHFR or Factor II Double Heterozygocity as a Risk Factor (2003) (4)
- Malignancies in Pregnancy 3 Haematological cancers in pregnancy (2012) (4)
- Outcome of cancer-associated venous thromboembolism is more favorable among patients with hematologic malignancies than in those with solid tumors. (2022) (3)
- Eosinophilic fibrohistiocytic lesion of bone marrow associated with monoclonal gammopathy and osteolytic lesions (1986) (3)
- Thrombophilia and cancer in the pathogenesis of arterial thrombosis (2000) (3)
- New insights into paediatric haemostasis: thrombosis and bleeding issues (2004) (3)
- [Is there an association between PUPPP and preeclampsia, abruptio placentae and fetal death?]. (2004) (3)
- Reduced protein C Global assay level in infertile women prior to IVF-ET treatment (2013) (3)
- Approach to the Evaluation and Treatment of Venous Thromboembolism in Pregnancy (2021) (3)
- Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia. (2017) (3)
- The prevalence and interaction of human immunodeficiency virus and hepatitis B virus infections in Israeli hemophiliacs. (1991) (3)
- A study of coagulation and anti-endothelial antibodies in idiopathic livedo reticularis. (1997) (3)
- Psychotropic Drugs and Outcome in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism (2020) (3)
- PAR1 Expression Predicts Clinical G-CSF CD34+ HSPC Mobilization and Repopulation Potential in Transplanted Patients (2019) (3)
- A prediction model for central venous catheter-related thrombosis in patients with newly-diagnosed acute myeloid leukemia: A derivation cohort analysis. (2022) (3)
- Abstract 10672: Incidence of Major Adverse Cardiovascular Events Among Patients With Provoked and Non-Provoked Venous Thromboembolism: A Review of the RIETE Registry (2018) (2)
- Early Bone Marrow Examination, On The Fifth Day Of Induction For AML, Is Highly Predictive Of Response (2013) (2)
- Hemostasis and Thrombosis in Extreme Physiological and Pathological Conditions (2018) (2)
- [Colonoscopy for early detection of colorectal cancer in average-risk population]. (2006) (2)
- Thrombophilia in pregnancy and its role in abortion. (2005) (2)
- Microparticles Induce Procoagulant and Apoptotic Effects on Endothelial Cells. (2006) (2)
- Myeloma and thrombotic complications. (2013) (2)
- Predicting the risk for major bleeding in elderly patients with venous thromboembolism using the Charlson index. Findings from the RIETE (2020) (2)
- PO-46 - Influence of extracellular vesicles derived from AML patients on stem cells and their microenvironment. (2016) (2)
- Travel-related thrombosis: is this a problem? (2006) (2)
- Venous thromboembolism risk, prophylaxis and management in cancer patients with COVID-19: An unmet medical need (2022) (2)
- Increased Heparanase Level and Procoagulant Activity in Orthopedic Surgery Patients Receiving Prophylactic Dose of Enoxaparin (2011) (2)
- [Symptomatic antiphospholipid antibody after neuroleptic drugs]. (1995) (2)
- State-of-the-art thrombosis prevention and treatment (2008) (2)
- Antithrombin III and preeclampsia. (1990) (1)
- The Use of Recombinant Factor VIIa in Platelet Disorders: Thrombocytopenia and Thrombocytopathia (2003) (1)
- [EXPERIENCE IN DIAGNOSTIC ASSAYS FOR HEPARIN-INDUCED THROMBOCYTOPENIA - EXPERIENCE OF A TERTIARY HOSPITAL IN ISRAEL]. (2019) (1)
- Cryogenic- and room-temperature electron microscopy imaging of MDA231 breast cancer cells and microparticles using immunogold labeling (2012) (1)
- First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry (2020) (1)
- Thrombosis in Pregnant Women with Hemolytic Anemia (2022) (1)
- Venous thromboembolism: advances and controversies. Preface. (2012) (1)
- [Warfarin therapy and hemarthrosis]. (2010) (1)
- Pregnancy should not rule out 18FDG PET/CT for women with cancer – Authors' reply (2012) (1)
- Thrombosis in Pregnant Women with Hematological Malignancies: A Case-Based Review (2022) (1)
- Thrombotic complications in patients with cancer: Advances in pathogenesis, prevention, and treatment—A report from ICTHIC 2021 (2022) (1)
- Associations of maternal and placental extracellular vesicle miRNA with preeclampsia (2023) (1)
- Inverse PAR1 Activity of Hematopoietic Stem Cells and BM Stromal Cells Mediates G-CSF-Induced Mobilization By Regulation of Nitric Oxide Generation (2016) (1)
- Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism (2021) (1)
- Women's Issues in Thrombophilia (2003) (1)
- Thrombophilia in Pregnancy and its Role in Abortion (2005) (1)
- Heparanase Activation of the Coagulation System in a Mice Sepsis Model (2011) (1)
- Coexistence of acquired protein S and protein C deficiency and the Arg506Gln mutation in factor Va in a child with severe thromboembolic disease (1998) (1)
- Low-Molecular-Weight Heparin in Pregnancy: State of the Art (2005) (1)
- 3 Microparticles have procoagulant and apoptotic effects on endothelial cells (2007) (1)
- Cancer and thrombosis. (2009) (1)
- Are platelet membrane glycoprotein polymorphisms predictive of arterial thrombosis? (2002) (1)
- Highlights of the 45th Annual Meeting of the American Society of Hematology (2004) (1)
- Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism. (2023) (1)
- Author Response: Precise Staging of Lymphoma during Pregnancy Using MRI is Not Always Crucial (2015) (1)
- Phase 3, Placebo-Controlled, ASPIRE Study (TRC114968) of Eltrombopag (EPAG) Treatment of Thrombocytopenia (TCP) in Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML): Assessment of Clinical Benefit, Safety, and Tolerability (2015) (1)
- C0292: The Role of Breast Cancer Cell Microparticles in Thrombogenicity, Angiogenesis and Apoptosis Following Chemotherapy (2014) (1)
- Managing thrombophilia during pregnancy (2010) (1)
- Papers and abstracts of the 9th International Conference on Thrombosis and Hemostasis Issues in Cancer (April 13-15, 2018-Bergamo, Italy) (2014) (0)
- Profile Of Microparticles In Patients With Acute Leukemia At Diagnosis and Upon Remission Induction (2013) (0)
- Thrombosis and Haemostasis Issues in Cancer: 2nd International Conference, Bergamo, September 2003: Lectures and Abstracts (2003) (0)
- Comparison of guidelines for evaluation of suspected PE in pregnancy: a cost-effectiveness analysis. (2021) (0)
- RECORD2: extended thromboprophylaxis with rivaroxaban versus short-term thromboprophylaxis with enoxaparin after total hip replacement (2008) (0)
- CA-125 as a Marker for the Early Diagnosis of Hepatic Veno-Occlusive Disease Following Hematopoietic Stem Cell Transplantation. (2004) (0)
- Thrombosis and Antithrombotic Therapy Reviewed (2001) (0)
- Low-molecular-weight heparin in women with repeated implantation failure (Women's Health (2011) 7: 4 (424-431)) (2011) (0)
- 0.09a Microparticles' effect on apoptosis, angiogenesis and migration in healthy and pathological pregnancies (2011) (0)
- Proceedings of the Fifth International Conference on Thrombosis and Hemostasis Issues in Cancer, held in Stresa, Italy, April 23-25, 2010. Preface. (2010) (0)
- Silent Pulmonary Embolism in Patients with Lower Limb Deep Vein Thrombosis (2011) (0)
- Maternal and Neonatal Hemostasis (2023) (0)
- Co-Interaction and Increased Release of Tissue Factor Pathway Inhibitor by Heparanase. (2005) (0)
- [New scoring system for estimating the risk for pregnancy complications and venous thromboembolism in women with thrombophilia]. (2011) (0)
- Lymphoma and Leukemia during Pregnancy (2013) (0)
- Microvesicles microRNAs Reflect and Affect Progression of Acute Myeloid Leukemia and Could Serve As a Biomarker of Disease Dynamics (2016) (0)
- [Budd-Chiari syndrome in polycythemia following phlebotomy]. (1985) (0)
- 6A.3 Debate: Antithrombotics for prevention of pregnancy loss – Yes (2007) (0)
- Should thromboprophylaxis be used in hereditary thrombophilias with RPL?: – For (2007) (0)
- 5. Severe thrombotic diathesis resulting from coexistence of dysfibrinogenemia and factor V Leiden (1996) (0)
- P-002: p45-NF-E2 regulates syncytiotrop formation in human placenta by modulation GCM-1 post translational modifications (2017) (0)
- 6th International Conference on Thrombosis and Hemostasis Issues in Cancer. Preface. (2012) (0)
- International Good Clinical Practices Guidelines (GCPG) for Antithrombotics in CANCER Patients (2012) (0)
- Can we program VTE prevention in pregnancy? (2015) (0)
- RECOMMENDED ARTICLE OF THE MONTH Comment on "Fibrinolysis for patients with intermediate-risk pulmonary embolism" (2015) (0)
- [Fever and neutropenias]. (1985) (0)
- 7th international conference on thrombosis and hemostasis issues in cancer. Preface. (2014) (0)
- Debate: Should Thromboprophylaxis Be Used in Hereditary Thrombophilias with Recurrent Pregnancy Loss? Yes (2014) (0)
- Inherited bleeding disorders in women (2002) (0)
- Effects of initial whole blood hematocrit on quantitative ultrasonic backscatter from blood clots in vitro (1989) (0)
- 45 Effect of fibrin matrices on increased proliferation and spreading of pre-term trophoblasts and placental villi modulation of coagulation and angiogenesis functions (2007) (0)
- P020: The management of pregnancy in a patient with hereditary combined deficiency of vitamin K dependent factors (2019) (0)
- C-deficient newborn with massive thrombosis large family of a previously described homozygous protein R506Q mutation of factor V and for T298M mutation of protein C in a Venous thromboembolism associated with double heterozygosity for (2011) (0)
- P-060: OTTILIA and FIRST: two international registries of foeto-maternal prognosis in women with recurrent reproductive failures after spontaneous or assisted conception (2017) (0)
- The role of breast cancer cell microparticles in thrombogenicity and angiogenesis following chemotherapy (2012) (0)
- Involvement of Heparanase in Early Pregnancy Losses (2008) (0)
- Abstract 5046: Nitric Oxide and Superoxide Dismutase Modulate Endothelial Progenitor Cell Function in Type 2 Diabetes Mellitus (2009) (0)
- Occult cancer in patients with acute venous thromboembolism: Why, when and where to investigate (2016) (0)
- Preface to the Proceedings of the 11th International Conference on Thrombosis and Hemostasis Issues in Cancer, 2022. (2022) (0)
- Postsplenectomy pericardial effusion in two patients with myeloid metaplasia. (1986) (0)
- mutation in the leucine-rich domain of glycoprotein IX Variant Bernard-Soulier syndrome associated with a homozygous (2011) (0)
- P8 Corpus luteum hemorrhage in women with bleeding disorders (2009) (0)
- Myeloproliferative neoplasms in pregnancy: ways to go (2016) (0)
- Antiphospholipid syndrome, heritable thrombophilia and early pregnancy loss (2008) (0)
- Abstracts from the Fourteenth Rambam Research Day, December 7, 2017 (2018) (0)
- The use of thrombophilia and pharmacological thromboprophylaxis screening in women: The benefits of the RIETE registry (2017) (0)
- Could arterial atherosclerosis herald cancer diagnosis? (2021) (0)
- An Open Label, Multi Center Study on the Efficacy and Safety of a Liquid, Ready-to-Use Intravenously Administered Anti-D Immunoglobulin in Patients with Chronic Immune Thrombocytopenic Purpura. (2004) (0)
- "Hematological malignancies occurring in pregnancy, although uncommon, present major diagnostic and therapeutic challenges." (2013) (0)
- P-001: Microparticles cause preeclampsia and embryonic growth restriction by platelet-mediated inflammasome activation in the embryonic trophoblast (2017) (0)
- of More Recent European Origin Another From Distinct Founders: One of Ancient Middle Eastern Origin and The Two Common Mutations Causing Factor XI Deficiency in Jews Stem (2013) (0)
- Natural course of HTLV-1 carriers with monoclonal proliferation of T lymphocytes ("pre-ATL") in a 20-year follow-up study (2017) (0)
- P7 Microparticles from women with gestational vascular complications (GVC) induce cells apoptosis and impaired tube formation (2009) (0)
- Role of Soluble Crosslinked Fibrin Polymers (2005) (0)
- HSP70 Is Increased in Circulating Extracellular Vesicles from Transfusion-Dependent β-Thalassemia Patients: Potential Biomarker for Ineffective Erythropoiesis (2016) (0)
- RECURRENT VENOUS THROMBOEMBOLISM IN PULMONARY EMBOLISM PATIENTS WITH RIGHT VENTRICULAR DYSFUNCTION IN THE HOKUSAI-VTE STUDY (2016) (0)
- Abstracts from Rambam Research Day, December 11, 2014 (2015) (0)
- Abstracts from the Thirteenth Rambam Research Day, December 22, 2016 (2017) (0)
- Superior vena cava thrombosis as a presenting syndrome of malignancy in a patient with lupus anticoagulant and hereditary protein C deficiency (1991) (0)
- AN EVALUATION OF THE EFFICACY AND SAFETY OF EXTENDED THROMBOPROPHYLAXIS WITH ORAL RIVAROXABAN COMPARED WITH SHORTTERM SUBCUTANEOUS ENOXAPARIN FOLLOWING TOTAL HIP REPLACEMENT (RECORD2: A PHASE III STUDY) (2010) (0)
- PAPER 147: RECORD2: A PHASE III EVALUATION OF THE EFFICACY AND SAFETY OF EXTENDED THROMBOPROPHYLAXIS WITH RIVAROXABAN COMPARED WITH SHORT-TERM ENOXAPARIN FOLLOWING TOTAL HIP REPLACEMENT (2010) (0)
- C0431 Microparticle TF/ TFPI Hemostatic Balance in Physiological and Pathological States (2012) (0)
- [ACQUIRED HEMOPHILIA A AND THE TIMING OF IMMUNOMODULATORY THERAPY]. (2019) (0)
- Identifying Women at High Risk of Venous Thrombosis before Administration of Hormone Therapy (2007) (0)
- [Sentinel lymph node sampling in breast carcinoma]. (2000) (0)
- NORMAL RESPONSE OF FACTOR (F)-VIII AND VONWILLEBRAND FACTOR (VWF) TO DDAVP IN NEPHRDGENIC DIABETES INSIPIDUS (NDI)) (1987) (0)
- Protein C global assay evaluation in naturally conceived vs. assisted reproduction-achieved twin pregnancies: a prospective longitudinal study (2021) (0)
- Binding of immunoglobulin from patients with lupus anticoagulant to endothelial cells ? Possible association with thrombosis (1992) (0)
- Deficiency of All Vitamin K-Dependent Blood Coagulation Factors -Glutamyl Carboxylase Gene Causes Combined γ A Missense Mutation in (2012) (0)
- P046: Proposed methodology to determine the optimal diagnostic strategy for pregnant women with suspicion of pulmonary embolism (2019) (0)
- Improving pregnancy outcome in women with thrombophilia (2004) (0)
- Thrombophilia and the Risk of Venous Thromboembolism in Cancer (2004) (0)
- Inhaled beta2-adrenoreceptor agonist elicits hypercoagulability state (2011) (0)
- The International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC) at the Peak of Adolescence - 15 Years and Counting. (2016) (0)
- Expression and Characterization of the Naturally Occurring Mutation L394R in Human Î3-Glutamyl Carboxylase* (2000) (0)
- PROPHYLAXIS AND TREATMENT OF THROMBOEMBOLISM I THROMBOPHILIA AND PREGNANCY COMPLICATIONS (2008) (0)
- The impact of heparanase on cancer progression (2009) (0)
- Author's reply to: Al-Abdi SY. Virus-inactivated plasma and intraventricular hemorrhage in preterm neonates (2014) (0)
- How to calculate the maximum risk— reply (1994) (0)
- 456 The involvement of placental and extracellular vesicles micro-RNA in the pathophysiology of gestational vascular complications (2021) (0)
- Editorial: Thrombotic Disorders, Prothrombotic Abnormalities and COVID-19 (2021) (0)
- Preface to the Proceedings of the 10th International Conference on Thrombosis and Hemostasis Issues in Cancer, 2020 (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Benjamin R. Brenner?
Benjamin R. Brenner is affiliated with the following schools: